Determination of potentially novel compensatory mutations in rpoc associated with rifampin resistance and rpob mutations in Mycobacterium tuberculosis Clinical isolates from peru

Background: Rifampicin (RIF) resistance in Mycobacterium tuberculosis is frequently caused by mutations in the rpoB gene. These mutations are associated with a fitness cost, which can be overcome by compensatory mutations in other genes, among which rpoC may be the most important. We analyzed 469 Pe...

Full description

Bibliographic Details
Main Authors: Ana Paula Vargas, Angela A Rios, Louis Grandjean, Daniela E Kirwan, Robert H Gilman, Patricia Sheen, Mirko J Zimic
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:International Journal of Mycobacteriology
Subjects:
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2020;volume=9;issue=2;spage=121;epage=137;aulast=Vargas
id doaj-f5c81f79329243759f55356d9d1648eb
record_format Article
spelling doaj-f5c81f79329243759f55356d9d1648eb2020-11-25T03:20:04ZengWolters Kluwer Medknow PublicationsInternational Journal of Mycobacteriology2212-55312212-554X2020-01-019212113710.4103/ijmy.ijmy_27_20Determination of potentially novel compensatory mutations in rpoc associated with rifampin resistance and rpob mutations in Mycobacterium tuberculosis Clinical isolates from peruAna Paula VargasAngela A RiosLouis GrandjeanDaniela E KirwanRobert H GilmanPatricia SheenMirko J ZimicBackground: Rifampicin (RIF) resistance in Mycobacterium tuberculosis is frequently caused by mutations in the rpoB gene. These mutations are associated with a fitness cost, which can be overcome by compensatory mutations in other genes, among which rpoC may be the most important. We analyzed 469 Peruvian M. tuberculosis clinical isolates to identify compensatory mutations in rpoC/rpoA associated with RIF resistance. Methods: The M. tuberculosis isolates were collected and tested for RIF susceptibility and spoligotyping. Samples were sequenced and aligned to the reference genome to identify mutations. By analyzing the sequences and the metadata, we identified a list of rpoC mutations exclusively associated with RIF resistance and mutations in rpoB. We then evaluated the distribution of these mutations along the protein sequence and tridimensional structure. Results: One hundred and twenty-five strains were RIF susceptible and 346 were resistant. We identified 35 potential new compensatory mutations, some of which were distributed on the interface surface between rpoB and rpoC, arising in clusters and suggesting the presence of hotspots for compensatory mutations. Conclusion: This study identifies 35 putative novel compensatory mutations in the β' subunit of M. tuberculosis RNApol. Six of these (S428T, L507V, A734V, I997V, and V1252LM) are considered most likely to have a compensatory role, as they fall in the interaction zone of the two subunits and the mutation did not lead to any change in the protein's physical–chemical properties.http://www.ijmyco.org/article.asp?issn=2212-5531;year=2020;volume=9;issue=2;spage=121;epage=137;aulast=Vargascompensatory mutationsevolutionrifampicin resistancerpobrpoctuberculosi
collection DOAJ
language English
format Article
sources DOAJ
author Ana Paula Vargas
Angela A Rios
Louis Grandjean
Daniela E Kirwan
Robert H Gilman
Patricia Sheen
Mirko J Zimic
spellingShingle Ana Paula Vargas
Angela A Rios
Louis Grandjean
Daniela E Kirwan
Robert H Gilman
Patricia Sheen
Mirko J Zimic
Determination of potentially novel compensatory mutations in rpoc associated with rifampin resistance and rpob mutations in Mycobacterium tuberculosis Clinical isolates from peru
International Journal of Mycobacteriology
compensatory mutations
evolution
rifampicin resistance
rpob
rpoc
tuberculosi
author_facet Ana Paula Vargas
Angela A Rios
Louis Grandjean
Daniela E Kirwan
Robert H Gilman
Patricia Sheen
Mirko J Zimic
author_sort Ana Paula Vargas
title Determination of potentially novel compensatory mutations in rpoc associated with rifampin resistance and rpob mutations in Mycobacterium tuberculosis Clinical isolates from peru
title_short Determination of potentially novel compensatory mutations in rpoc associated with rifampin resistance and rpob mutations in Mycobacterium tuberculosis Clinical isolates from peru
title_full Determination of potentially novel compensatory mutations in rpoc associated with rifampin resistance and rpob mutations in Mycobacterium tuberculosis Clinical isolates from peru
title_fullStr Determination of potentially novel compensatory mutations in rpoc associated with rifampin resistance and rpob mutations in Mycobacterium tuberculosis Clinical isolates from peru
title_full_unstemmed Determination of potentially novel compensatory mutations in rpoc associated with rifampin resistance and rpob mutations in Mycobacterium tuberculosis Clinical isolates from peru
title_sort determination of potentially novel compensatory mutations in rpoc associated with rifampin resistance and rpob mutations in mycobacterium tuberculosis clinical isolates from peru
publisher Wolters Kluwer Medknow Publications
series International Journal of Mycobacteriology
issn 2212-5531
2212-554X
publishDate 2020-01-01
description Background: Rifampicin (RIF) resistance in Mycobacterium tuberculosis is frequently caused by mutations in the rpoB gene. These mutations are associated with a fitness cost, which can be overcome by compensatory mutations in other genes, among which rpoC may be the most important. We analyzed 469 Peruvian M. tuberculosis clinical isolates to identify compensatory mutations in rpoC/rpoA associated with RIF resistance. Methods: The M. tuberculosis isolates were collected and tested for RIF susceptibility and spoligotyping. Samples were sequenced and aligned to the reference genome to identify mutations. By analyzing the sequences and the metadata, we identified a list of rpoC mutations exclusively associated with RIF resistance and mutations in rpoB. We then evaluated the distribution of these mutations along the protein sequence and tridimensional structure. Results: One hundred and twenty-five strains were RIF susceptible and 346 were resistant. We identified 35 potential new compensatory mutations, some of which were distributed on the interface surface between rpoB and rpoC, arising in clusters and suggesting the presence of hotspots for compensatory mutations. Conclusion: This study identifies 35 putative novel compensatory mutations in the β' subunit of M. tuberculosis RNApol. Six of these (S428T, L507V, A734V, I997V, and V1252LM) are considered most likely to have a compensatory role, as they fall in the interaction zone of the two subunits and the mutation did not lead to any change in the protein's physical–chemical properties.
topic compensatory mutations
evolution
rifampicin resistance
rpob
rpoc
tuberculosi
url http://www.ijmyco.org/article.asp?issn=2212-5531;year=2020;volume=9;issue=2;spage=121;epage=137;aulast=Vargas
work_keys_str_mv AT anapaulavargas determinationofpotentiallynovelcompensatorymutationsinrpocassociatedwithrifampinresistanceandrpobmutationsinmycobacteriumtuberculosisclinicalisolatesfromperu
AT angelaarios determinationofpotentiallynovelcompensatorymutationsinrpocassociatedwithrifampinresistanceandrpobmutationsinmycobacteriumtuberculosisclinicalisolatesfromperu
AT louisgrandjean determinationofpotentiallynovelcompensatorymutationsinrpocassociatedwithrifampinresistanceandrpobmutationsinmycobacteriumtuberculosisclinicalisolatesfromperu
AT danielaekirwan determinationofpotentiallynovelcompensatorymutationsinrpocassociatedwithrifampinresistanceandrpobmutationsinmycobacteriumtuberculosisclinicalisolatesfromperu
AT roberthgilman determinationofpotentiallynovelcompensatorymutationsinrpocassociatedwithrifampinresistanceandrpobmutationsinmycobacteriumtuberculosisclinicalisolatesfromperu
AT patriciasheen determinationofpotentiallynovelcompensatorymutationsinrpocassociatedwithrifampinresistanceandrpobmutationsinmycobacteriumtuberculosisclinicalisolatesfromperu
AT mirkojzimic determinationofpotentiallynovelcompensatorymutationsinrpocassociatedwithrifampinresistanceandrpobmutationsinmycobacteriumtuberculosisclinicalisolatesfromperu
_version_ 1724619508493058048